Clinical Trials Sponsored by Department of Internal Medicine V, Thoracic Oncology Centre Munich, LMU Munich, Munich, Germany

Total 3 results

LMU Klinikum
Department of Internal Medicine V, Thoracic Oncology Centre Munich, LMU Munich... and other collaborators

Recruiting

Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab (PRECISION)

Oncology | NSCLC, Stage III | Chemoradiotherapy | Biomarker | Durvalumab

Germany
Michael Hoelscher
National Institute for Medical Research - Mbeya Medical Research Centre (NIMR-MMRC) and other collaborators

Active, not recruiting

Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania. (bNAb)

HIV/AIDS

Tanzania
San Raffaele University
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Ospedale... and other collaborators

Recruiting

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer (DEMETRA)

Colorectal Cancer | Diet Habit | Risk Reduction | Early Onset Colorectal Cancer

United States, Finland, Germany, Italy, Norway, Spain

3

Subscribe